Activation of the GLP-1 receptor by a non-peptidic agonist.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
10
05
2019
accepted:
08
11
2019
pubmed:
10
1
2020
medline:
28
4
2020
entrez:
10
1
2020
Statut:
ppublish
Résumé
Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, including diabetes and obesity
Identifiants
pubmed: 31915381
doi: 10.1038/s41586-019-1902-z
pii: 10.1038/s41586-019-1902-z
doi:
Substances chimiques
Glucagon-Like Peptide-1 Receptor
0
Isoquinolines
0
Pyridines
0
TT-OAD2
0
Phenylalanine
47E5O17Y3R
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
432-436Commentaires et corrections
Type : CommentIn
Références
Bortolato, A. et al. Structure of class B GPCRs: new horizons for drug discovery. Br. J. Pharmacol. 171, 3132–3145 (2014).
pubmed: 24628305
pmcid: 4080969
Liang, Y. L. et al. Cryo-EM structure of the active, G
pubmed: 30209400
pmcid: 6166790
Liang, Y. L. et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex. Nature 555, 121–125 (2018).
pubmed: 29466332
Liang, Y. L. et al. Phase-plate cryo-EM structure of a class B GPCR-G-protein complex. Nature 546, 118–123 (2017).
pubmed: 28437792
pmcid: 5832441
Zhao, L. H. et al. Structure and dynamics of the active human parathyroid hormone receptor-1. Science 364, 148–153 (2019).
pubmed: 30975883
pmcid: 6929210
Zhang, Y. et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature 546, 248–253 (2017).
pubmed: 28538729
pmcid: 5587415
Siu, F. Y. et al. Structure of the human glucagon class B G-protein-coupled receptor. Nature 499, 444–449 (2013).
pubmed: 23863937
Zhang, H. et al. Structure of the full-length glucagon class B G-protein-coupled receptor. Nature 546, 259–264 (2017).
pubmed: 28514451
pmcid: 5492955
Zhang, H. et al. Structure of the glucagon receptor in complex with a glucagon analogue. Nature 553, 106–110 (2018).
pubmed: 29300013
Song, G. et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators. Nature 546, 312–315 (2017).
pubmed: 28514449
Htike, Z. Z. et al. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis. Diabetes Obes. Metab. 19, 524–536 (2017).
pubmed: 27981757
Aroda, V. R. et al. PIONEER 1: Randomized clinical trial comparing the efficacy and safety of oral semaglutide monotherapy with placebo in patients with type 2 diabetes. Diabetes Care 42, dc190749 (2019).
Pratley, R. et al. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet 394, 39–50 (2019).
pubmed: 31186120
Wootten, D. et al. Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands. Mol. Pharmacol. 83, 822–834 (2013).
pubmed: 23348499
Nolte, W. M. et al. A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification. Nat. Chem. Biol. 10, 629–631 (2014).
pubmed: 24997604
Freeman, J. W. S. et al. TTP273: Oral, G protein pathway selective clinical-stage GLP-1 receptor (GLP-1R) agonist. Keystone Symposium, Keystone, CO February 22 http://vtvtherapeutics.com/wp-content/uploads/pdf/GLP1_poster_animation_Keystone_CO_FINAL.pdf (2016).
Chen, D. et al. A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice. Proc. Natl Acad. Sci. USA 104, 943–948 (2007).
pubmed: 17213311
Jazayeri, A. et al. Crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature 546, 254–258 (2017).
pubmed: 28562585
Freeman, J. D. C., Dunn, I. & Valcarce, C. TTP273, Oral (nonpeptide) GLP-1R agonist: improved glycemic control without nausea and vomiting in phase 2. American Diabetes Association 77th Scientific Sessions, San Diego, CA, June 9–13, 2017 http://vtvtherapeutics.com/wp-content/uploads/pdf/ADA_Logra_study_results_poster_1220-P%20Final.pdf (2017).
Runge, S., Thøgersen, H., Madsen, K., Lau, J. & Rudolph, R. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J. Biol. Chem. 283, 11340–11347 (2008).
pubmed: 18287102
DeVree, B. T. et al. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs. Nature 535, 182–186 (2016).
pubmed: 27362234
pmcid: 5702553
Yin, Y. et al. An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain. Cell Discov. 2, 16042 (2016).
pubmed: 27917297
pmcid: 5118412
Zhao, L. H. et al. Differential requirement of the extracellular domain in activation of class B G protein-coupled receptors. J. Biol. Chem. 291, 15119–15130 (2016).
pubmed: 27226600
pmcid: 4946928
Ehrenmann, J. et al. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist. Nat. Struct. Mol. Biol. 25, 1086–1092 (2018).
pubmed: 30455434
Yang, L. et al. Conformational states of the full-length glucagon receptor. Nat. Commun. 6, 7859 (2015).
pubmed: 26227798
pmcid: 4532856
Wootten, D., Simms, J., Miller, L. J., Christopoulos, A. & Sexton, P. M. Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc. Natl Acad. Sci. USA 110, 5211–5216 (2013).
pubmed: 23479653
dal Maso, E. et al. The molecular control of calcitonin receptor signaling. ACS Pharmacol. Transl. Sci. 2, 31–51 (2019).
Wootten, D. et al. The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism. Cell 165, 1632–1643 (2016).
pubmed: 27315480
pmcid: 4912689
Lei, S. et al. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism. J. Biol. Chem. 293, 9370–9387 (2018).
pubmed: 29717000
pmcid: 6005446
Liang, Y.-L. et al. Dominant negative G proteins enhance formation and purification of agonist-GPCR-G protein complexes for structure determination. ACS Pharmacol. Transl. Sci. 1, 9 (2018).
Furness, S. G. B. et al. Ligand-dependent modulation of G protein conformation alters drug efficacy. Cell 167, 739–749.e711 (2016).
pubmed: 27720449
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466
pmcid: 28250466
Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
pubmed: 4711343
pmcid: 4711343
Nakane, T., Kimanius, D., Lindahl, E. & Scheres, S. H. Characterisation of molecular motions in cryo-EM single-particle data by multi-body refinement in RELION. eLife 7, e36861 (2018).
pubmed: 29856314
pmcid: 6005684
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).
pubmed: 6250425
pmcid: 6250425
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63–65 (2014).
pubmed: 24213166
Chan, K. Y., Trabuco, L. G., Schreiner, E. & Schulten, K. Cryo-electron microscopy modeling by the molecular dynamics flexible fitting method. Biopolymers 97, 678–686 (2012).
pubmed: 22696404
pmcid: 3376020
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D 65, 1074–1080 (2009).
pubmed: 19770504
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins 55, 351–367 (2004).
pubmed: 15048827
Eswar, N. et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5, Unit 5.6 (2006).
pubmed: 18428767
Vohra, S. et al. Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies. J. R. Soc. Interface 10, 20120846 (2012).
pubmed: 23235263
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph 14, 33–38 (1996).
pubmed: 8744570
Rasmussen, S. G. et al. Crystal structure of the β
pubmed: 21772288
pmcid: 3184188
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. & Tate, C. G. Structure of the adenosine A
pubmed: 27462812
pmcid: 4979997
Huang, J. & MacKerell, A. D. Jr. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 34, 2135–2145 (2013).
pubmed: 23832629
pmcid: 3800559
Doerr, S., Harvey, M. J., Noé, F. & De Fabritiis, G. HTMD: high-throughput molecular dynamics for molecular discovery. J. Chem. Theory Comput. 12, 1845–1852 (2016).
pubmed: 26949976
Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson–Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665–W667 (2004).
pubmed: 15215472
pmcid: 441519
Olsson, M. H., Søndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: consistent treatment of internal and surface residues in empirical pka predictions. J. Chem. Theory Comput. 7, 525–537 (2011).
pubmed: 26596171
Lomize, M. A., Lomize, A. L., Pogozheva, I. D. & Mosberg, H. I. OPM: orientations of proteins in membranes database. Bioinformatics 22, 623–625 (2006).
pubmed: 16397007
Sommer, B. Membrane packing problems: a short review on computational membrane modeling methods and tools. Comput. Struct. Biotechnol. J. 5, e201302014 (2013).
pubmed: 24688707
pmcid: 3962210
Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671–690 (2010).
pubmed: 19575467
pmcid: 2888302
Vanommeslaeghe, K. & MacKerell, A. D. Jr. Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model. 52, 3144–3154 (2012).
pubmed: 23146088
pmcid: 3528824
Vanommeslaeghe, K., Raman, E. P. & MacKerell, A. D. Jr. Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J. Chem. Inf. Model. 52, 3155–3168 (2012).
pubmed: 23145473
pmcid: 3528813
Harvey, M. J., Giupponi, G. & Fabritiis, G. D. ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale. J. Chem. Theory Comput. 5, 1632–1639 (2009).
pubmed: 26609855
Loncharich, R. J., Brooks, B. R. & Pastor, R. W. Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N'-methylamide. Biopolymers 32, 523–535 (1992).
pubmed: 1515543
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684 (1984).
Kräutler, V. G., van Gunsteren, W. F. & Hünenberger, P. H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22, 501–508 (2001).
Essmann, U. P. & Berkowitz, L. M.L. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577 (1995).
Cuzzolin, A., Deganutti, G., Salmaso, V., Sturlese, M. & Moro, S. AquaMMapS: an alternative tool to monitor the role of water molecules during protein-ligand association. ChemMedChem 13, 522–531 (2018).
pubmed: 29193885
Wall, M. E., Calabró, G., Bayly, C. I., Mobley, D. L. & Warren, G. L. Biomolecular solvation structure revealed by molecular dynamics simulations. J. Am. Chem. Soc. 141, 4711–4720 (2019).
pubmed: 30834751
Koole, C. et al. Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening. Mol. Pharmacol. 78, 456–465 (2010).
pubmed: 20547734
pmcid: 3202488
Savage, E. E., Wootten, D., Christopoulos, A., Sexton, P. M. & Furness, S. G. A simple method to generate stable cell lines for the analysis of transient protein-protein interactions. Biotechniques 54, 217–221 (2013).
pubmed: 23581469
Jun, L. S. et al. A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor. PLoS One 9, e93746 (2014).
pubmed: 24695667
pmcid: 3973576